BENCHMARK ANIMAL HEALTH LIMITED
Get an alert when BENCHMARK ANIMAL HEALTH LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Cash
£478k
+101% vs 2023
Net assets
-£95m
-27.5% vs 2023
Employees
26
-39.5% vs 2023
Profit before tax
-£21m
-102.6% vs 2023
Watchouts
Facts from the Companies House register and the latest accounts — not a rating
-
Negative shareholders' funds
Net assets
2-year trend · vs Consumer Discretionary median
Accounts
2-year trend · Δ = latest vs prior filed period · latest reflected 2024-09-30
| Metric | Trend | 2023-09-30 | 2024-09-30 | Δ vs prior |
|---|---|---|---|---|
| Turnover | £24,020,194 | £13,956,891 | -41.9% | |
| Operating profit | -£9,455,166 | -£20,654,065 | -118.4% | |
| Profit before tax | -£10,347,275 | -£20,958,493 | -102.6% | |
| Net profit | -£10,502,311 | -£20,881,198 | -98.8% | |
| Cash | £237,647 | £477,618 | +101% | |
| Total assets less current liabilities | -£69,881,256 | -£94,836,312 | -35.7% | |
| Net assets | -£74,424,336 | -£94,877,316 | -27.5% | |
| Equity | — | — | — | |
| Average employees | 43 | 26 | -39.5% | |
| Wages | £5,167,179 | £2,267,790 | -56.1% | |
| Directors' remuneration | £431,076 | £0 | -100% | |
| Directors' pension contributions | £15,226 | £0 | -100% |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. The Δ column is the change from the prior filed period as a percentage of |prior|; lines a company doesn't report show —. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-09-30 | 2024-09-30 |
|---|---|---|---|
| Operating margin | -39.4% | -148.0% | |
| Net margin | -43.7% | -149.6% | |
| Gearing (liabilities / total assets) | 284.4% | 903.8% | |
| Current ratio | 0.12x | 0.10x | |
| Interest cover | -10.53x | -67.11x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Name history
Renamed 1 time since incorporation
- BENCHMARK ANIMAL HEALTH LIMITED 2014-02-19 → present
- ENDEAVOUR 142 LIMITED 2014-01-31 → 2014-02-19
Audit & accounting basis
- Accounting basis
- FRS 101
- Reporting scope
- Standalone (parent only)
- Auditor
- KPMG LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The Directors' have reviewed the Group's forecast for a period of at least 12 months from the date of approval of the financial statements and concluded that the Company should be able to continue to operate as a going concern. Further details are provided in note 2 to the financial statements.”
Group structure
- BENCHMARK ANIMAL HEALTH LIMITED · parent
- Benchmark Animal Health US, Inc 100%
- Benchmark Animal Health Inc 100%
- Benchmark R&D (Thailand) Limited 100%
- Benchmark Animal Health Chile SpA 100%
Significant events
- “The Health division underwent a significant restructuring in FY24 to create a sustainable and profitable business, concentrating on the core sea lice solution, Salmosan® Vet, while maintaining the capability to deploy Ectosan® Vet and CleanTreat® in the future.”
- “Transitioned CleanTreat® from the PSV model to a future customer-owned infrastructure model, reducing fixed costs and capital exposure.”
- “Successfully demobilised both CleanTreat® PSVs in Q2 and Q3, leading to significant cost savings.”
- “capitalised development costs relating to Ectosan® Vet/CleanTreat® of £13.3m were impaired to nil.”
- “On 25 November, an agreement was signed for the Group to sell the whole Genetics business for consideration of up to £260m, with £230m received up front and up to £30m earnout receivable in three years. Completion of the deal took place on 31 March 2025”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
2 active · 10 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| HUGO, Pierre Joseph Jean | Director | 2025-09-30 | Dec 1971 | Belgian |
| ROSENLUND, Sindre Frivik | Director | 2025-09-30 | Jan 1992 | Norwegian |
Show 10 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| BONNEY, Roland James | Director | 2014-01-31 | 2019-09-30 |
| DAVY, Christopher John | Director | 2017-01-05 | 2021-03-23 |
| KNOTT, Stephen Wesley Andrew | Director | 2018-10-02 | 2020-05-31 |
| MAGUIRE, Septima | Director | 2021-03-23 | 2025-07-31 |
| MARSHALL, John William | Director | 2014-01-31 | 2023-06-30 |
| MATHIASSEN, Fredrik Andre | Director | 2025-07-31 | 2025-09-30 |
| PLAMPIN, Mark James | Director | 2014-01-31 | 2019-12-20 |
| PYE, Malcolm David Foster | Director | 2014-01-31 | 2019-11-30 |
| WARDLE, Robin Glevum | Director | 2017-01-05 | 2019-07-02 |
| WILLIKSEN, Trond | Director | 2020-09-28 | 2025-08-31 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Benchmark Animal Health Group Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2016-04-06 | Active |
Filing timeline
Last 20 of 75 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2025-11-06 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-10-03 | AP01 | officers | Appoint person director company with name date | |
| 2025-10-03 | TM01 | officers | Termination director company with name termination date | |
| 2025-10-03 | AP01 | officers | Appoint person director company with name date | |
| 2025-09-03 | TM01 | officers | Termination director company with name termination date | |
| 2025-08-01 | AP01 | officers | Appoint person director company with name date | |
| 2025-08-01 | TM01 | officers | Termination director company with name termination date | |
| 2025-07-07 | AA | accounts | Accounts with accounts type full | |
| 2025-04-02 | MR01 | mortgage | Mortgage create with deed with charge number charge creation date | |
| 2024-12-09 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-12-09 | CH01 | officers | Change person director company with change date | |
| 2024-05-16 | AA | accounts | Accounts with accounts type full | |
| 2023-12-05 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-07-06 | AA | accounts | Accounts with accounts type full | |
| 2023-06-30 | TM01 | officers | Termination director company with name termination date | |
| 2022-12-05 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2022-11-29 | MR01 | mortgage | Mortgage create with deed with charge number charge creation date | |
| 2022-11-24 | MR04 | mortgage | Mortgage satisfy charge full | |
| 2022-11-21 | CH01 | officers | Change person director company with change date | |
| 2022-11-14 | CH01 | officers | Change person director company with change date |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 4
- Capital events
- 0
- Officers appointed
- 0
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.